Preprint · OA
via OpenAlex
P04.24 * MUTATIONS OF THE TERT PROMOTER CORRELATE WITH ENHANCED TELOMERASE ACTIVATION AND PREDICT A WORSE PROGNOSIS IN PRIMARY GLIOBLASTOMA PATIENTS
Sabine Spiegl‐Kreinecker, Daniela Loetsch, Magdalena Laaber, Josef Pichler, Stefan Weis, Bahil Ghanim, Gerald Webersinke, A Olschowski, Walter Berger
Neuro-Oncology · 2014 · ▲ 1 citations
Abstract
The stabilization of telomeres by upregulation of telomerase is compulsive for indefinite proliferation and cell immortalization therefore representing a main feature of malignant solid tumors, including gliomas. However, the mechanisms responsible for cancer-associated telomerase activation are not completely understood. Recently, defined mutations in the TERT promoter were identified in a variety of tumors, most frequent in primary glioblastomas (GBM). Presence of the mutations was associated with increased TERT expression. In the present study GBM derived tumor tissue from 126 patients operated at the Wagner Jauregg Hospital were screened for TERT promoter mutations. Subsequently the collected data were correlated with telomere(definition) associated parameters (telomerase activity, TERT mRNA expression, telomere lengths), the glioma biomarkers MGMT promoter methylation and IDH1 mutation as well as clinical parameters including patient survival. Using direct sequencing, the TERT promoter mutations (C228T, C250T) were found in 73% of tumors with predominance of C228T (72% of the mutated cases). Thirty-four (27%) samples contained none of the investigated TERT promoter mutations while mutations at both sites occurred in none of the investigated GBM cases. TERT promoter mutations were accompanied by a significant upregulation of telomerase activity (p = 0.0005) and TERT mRNA expression (p = 0.0004). Accordingly, telomere lengths of TERT promoter mutated tumors were significantly shorter compared to the TERT promoter wild-type subgroup (p = 0.001). Moreover, Kaplan-Meier survival analyses revealed a significantly shorter overall survival for GBM patients harbouring mutant tumors (p < 0.0001). In the multivariate Cox regression analysis TERT promoter mutation was found to have independent prognostic power (p = 0.049) but reached elevated significance in the interaction with age (p = 0.007). Accordingly, the prognostic quality of TERT promoter mutations was confined to the subgroup of patients aged younger than 65 years and completely absent in the older patient cohort. Significantly enhanced TERT mRNA expression and reduced telomere lengths in the aged patients were only observed in the subgroup lacking TERT promoter mutations. Summarizing, these results suggest that the negative prognostic value of TERT promoter mutation is restricted to patients of younger age further corroborating age-associated differences in the way of glioblastoma-associated telomere stabilization.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/neuonc/nou174.156
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Spiegl‐Kreinecker, S., Loetsch, D., Laaber, M., Pichler, J., Weis, S., Ghanim, B., Webersinke, G., Olschowski, A., & Berger, W. (2014). P04.24 * MUTATIONS OF THE TERT PROMOTER CORRELATE WITH ENHANCED TELOMERASE ACTIVATION AND PREDICT A WORSE PROGNOSIS IN PRIMARY GLIOBLASTOMA PATIENTS. <em>Neuro-Oncology</em>. https://doi.org/10.1093/neuonc/nou174.156
Vancouver
Spiegl‐Kreinecker S, Loetsch D, Laaber M, Pichler J, Weis S, Ghanim B, et al. P04.24 * MUTATIONS OF THE TERT PROMOTER CORRELATE WITH ENHANCED TELOMERASE ACTIVATION AND PREDICT A WORSE PROGNOSIS IN PRIMARY GLIOBLASTOMA PATIENTS. Neuro-Oncology. 2014. doi:10.1093/neuonc/nou174.156.
BibTeX
@unpublished{sabine2014PMUTAT,
title = {P04.24 * MUTATIONS OF THE TERT PROMOTER CORRELATE WITH ENHANCED TELOMERASE ACTIVATION AND PREDICT A WORSE PROGNOSIS IN PRIMARY GLIOBLASTOMA PATIENTS},
author = {Sabine Spiegl‐Kreinecker and Daniela Loetsch and Magdalena Laaber and Josef Pichler and Stefan Weis and Bahil Ghanim and Gerald Webersinke and A Olschowski and Walter Berger},
journal = {Neuro-Oncology},
year = {2014},
doi = {10.1093/neuonc/nou174.156},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Neuro-Oncology 2015
Preprint · OA
Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis
Neuro-Oncology 2013
Preprint · OA
Prognostic significance of telomerase-associated parameters in glioblastoma: effect of patient age
Journal of Clinical Oncology 2026
Citation only
Transcriptomic signature of temozolomide treatment-effect heterogeneity in IDH-wildtype glioblastoma.
Journal of Clinical Oncology 2004
Open access · OA
Telomere Length and Human Telomerase Reverse Transcriptase Expression As Markers for Progression and Prognosis of Colorectal Carcinoma
Figshare 2015
Preprint · OA
TELOMERASE ACTIVATION AND ITS CLINICAL IMPLICATIONS IN HUMAN THYROID TUMORS
BMC Genomics 2010
Open access · CC-BY